BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

236 related articles for article (PubMed ID: 19124407)

  • 1. The safety of drug-eluting stents.
    Saia F; Marzocchi A; Branzi A
    Ther Adv Cardiovasc Dis; 2008 Feb; 2(1):43-52. PubMed ID: 19124407
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The conundrum of late and very late stent thrombosis following drug-eluting stent implantation.
    Garg P; Mauri L
    Curr Opin Cardiol; 2007 Nov; 22(6):565-71. PubMed ID: 17921745
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Drug-eluting stent thrombosis.
    Steinberg DH; Satler LF
    Minerva Cardioangiol; 2008 Feb; 56(1):127-37. PubMed ID: 18432175
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Drug-eluting stent safety.
    Slottow TL; Waksman R
    Am J Cardiol; 2007 Oct; 100(8B):10M-17M. PubMed ID: 17950827
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Long-term outcomes in patients undergoing percutaneous coronary intervention with drug-eluting stents.
    Rossini R; Musumeci G; Aprile A; Valsecchi O
    Expert Rev Pharmacoecon Outcomes Res; 2010 Feb; 10(1):49-61. PubMed ID: 20121564
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Drug-eluting stents in primary percutaneous coronary intervention for ST-elevation myocardial infarction: an up-to-date review of the literature.
    Ehdaie A; Lee MS
    Minerva Cardioangiol; 2009 Oct; 57(5):645-55. PubMed ID: 19838154
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Drug-eluting stents: issues of late stent thrombosis.
    Lemesle G; Maluenda G; Collins SD; Waksman R
    Cardiol Clin; 2010 Feb; 28(1):97-105. PubMed ID: 19962052
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Off-label use of stents: bare-metal versus drug-eluting stents.
    Girod JP; Mulukutla SR; Marroquin OC
    Expert Rev Cardiovasc Ther; 2008 Sep; 6(8):1095-106. PubMed ID: 18793112
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Antiplatelet therapy in the era of drug-eluting stents: current and future perspectives.
    Ducrocq G; Serebruany V; Tanguay JF
    Expert Rev Cardiovasc Ther; 2007 Sep; 5(5):939-53. PubMed ID: 17867923
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Late and very late thrombosis of drug-eluting stents: evolving concepts and perspectives.
    Jaffe R; Strauss BH
    J Am Coll Cardiol; 2007 Jul; 50(2):119-27. PubMed ID: 17616295
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Coexistent in-stent restenosis, late incomplete stent apposition and mural thrombus in a zotarolimus-eluting stent.
    Zhang F; Qian J; Ge J
    J Invasive Cardiol; 2008 Aug; 20(8):423-5. PubMed ID: 18688068
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Long-term safety and effectiveness of unprotected left main coronary stenting with drug-eluting stents compared with bare-metal stents.
    Kim YH; Park DW; Lee SW; Yun SC; Lee CW; Hong MK; Park SW; Seung KB; Gwon HC; Jeong MH; Jang Y; Kim HS; Seong IW; Park HS; Ahn T; Chae IH; Tahk SJ; Chung WS; Park SJ;
    Circulation; 2009 Aug; 120(5):400-7. PubMed ID: 19620506
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Late stent thrombosis with drug-eluting stents: the price to pay to prevent restenosis?
    Kumbhani DJ; Bavry AA; Bhatt DL
    Indian Heart J; 2007; 59(2 Suppl B):B113-7. PubMed ID: 19153427
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Drug-eluting coronary stents: many meta-analyses, little benefit.
    Prescrire Int; 2009 Apr; 18(100):70-4. PubMed ID: 19585727
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Safety of drug-eluting stents.
    Windecker S; Jüni P
    Nat Clin Pract Cardiovasc Med; 2008 Jun; 5(6):316-28. PubMed ID: 18414453
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Drug-eluting stents: a critique.
    Melikian N; Wijns W
    Heart; 2008 Feb; 94(2):145-52. PubMed ID: 18195121
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparison of outcomes of drug-eluting stents versus bare-metal stents in nonostial proximal left anterior descending coronary arteries.
    Bonello L; De Labriolle A; Lemesle G; Roy P; Steinberg DH; Slottow TL; Xue Z; Torguson R; Kaneshige K; Suddath WO; Satler LF; Kent KM; Lindsay J; Pichard AD; Waksman R
    Am J Cardiol; 2009 Feb; 103(4):496-500. PubMed ID: 19195509
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Off-label use of drug-eluting stents putting it in perspective.
    Grines CL
    J Am Coll Cardiol; 2008 Feb; 51(6):615-7. PubMed ID: 18261679
    [No Abstract]   [Full Text] [Related]  

  • 19. Percutaneous coronary intervention: assessing coronary vascular risk associated with bare-metal and drug-eluting stents.
    Spinler SA
    Am J Manag Care; 2009 Mar; 15(2 Suppl):S42-7. PubMed ID: 19355808
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Late stent thrombosis thirteen months after drug-eluting stent implantation].
    Sacha J; Wester A; Pluta W
    Kardiol Pol; 2008 Jan; 66(1):78-80; discussion 84-5. PubMed ID: 18266191
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.